IDEAYA Biosciences, Inc. (IDYA)
32.85
-1.00
(-2.95%)
USD |
NASDAQ |
Oct 16, 16:00
32.84
-0.01
(-0.03%)
After-Hours: 20:00
IDEAYA Biosciences Research and Development Expense (Annual) : 314.70M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 314.70M |
| December 31, 2024 | 294.67M |
| December 31, 2023 | 129.51M |
| December 31, 2022 | 89.54M |
| December 31, 2021 | 58.16M |
| Date | Value |
|---|---|
| December 31, 2020 | 39.70M |
| December 31, 2019 | 34.32M |
| December 31, 2018 | 31.75M |
| December 31, 2017 | 12.38M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 93.26M |
| Xencor, Inc. | 239.43M |
| BioMarin Pharmaceutical, Inc. | 700.97M |
| MediciNova, Inc. | 7.135M |
| Viking Therapeutics, Inc. | 344.96M |